A Single Center, Randomized, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, And Tolerability Of The Daily Co-administration Of Ezetimibe 10 Mg Or Ezetimibe Placebo To Ongoing Treatment With Atorvastatin 10 Mg In Subjects With Primary Hypercholesterolemia And Multiple Coronary Heart Disease Risk Factors in Indonesian Population.
Latest Information Update: 11 Feb 2022
Price :
$35 *
At a glance
- Drugs Atorvastatin (Primary) ; Ezetimibe (Primary)
- Indications Coronary arteriosclerosis; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Organon
- 09 May 2011 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
- 02 Feb 2007 Status changed from recruiting to in progress.
- 21 Jul 2006 New trial record.